Metastatic Breast Cancer Conference

August 09, 2016

Metastatic breast cancer, Stage IV, or advanced breast cancer is the spread of cancer cells beyond the breast to new areas of the body, often by way of the lymph system or bloodstream.

Metastases account for greater than 90% of cancer morbidity and mortality. In metastatic breast cancer this translates to nearly 40,000 deaths annually in the U.S. and more than 500,000 deaths worldwide. Metastatic breast cancer is the leading cause of cancer death in women below 50 years of age.

The Medical Conference will present updates on basic science, clinical, and survivorship issues that relate to the development, treatment, and sequelae of metastatic breast cancer. The integration of all three aspects is presented with the belief that collaboration across disciplines is required to understand and effectively treat disseminated disease.
-end-


Baylor College of Medicine

Related Metastatic Breast Cancer Articles from Brightsurf:

New research supports clinical utility of CTC count for metastatic breast cancer
Menarini Silicon Biosystems, the pioneer of liquid biopsy technology, today announced the publication of a research study providing support for the reliability of using circulating tumor cell (CTC) count to guide frontline therapy choice for patients with estrogen receptor-positive (ER+), HER2-negative (HER2) metastatic breast cancer.

Surgery and radiation do not extend survival in newly diagnosed metastatic breast cancer
Women who present with a new diagnosis of breast cancer that is already in an advanced stage (stage IV) face questions about having surgery and radiation to the tumor in the breast (local therapy).

Novel biomarkers predict benefit with immunotherapy in metastatic breast cancer
Two novel biomarkers have been found to correlate with improved outcomes with immunotherapy in metastatic breast cancer and may help to identify the patients most likely to benefit from this treatment, according to exploratory studies reported at the ESMO Breast Cancer Virtual Meeting 2020.

Activation of a distinct genetic pathway can slow the progress of metastatic breast cancer
Activation of the BMP4 signalling pathway presents a new therapeutic strategy to combat metastatic breast cancer, a disease that has shown no reduction in patient mortality over the past 20 years.

Hyperactive FOXA1 reprograms endocrine-resistant breast cancer to become metastatic
A team led by researchers at Baylor College of Medicine and Harvard Medical School has unveiled a novel mechanism that helps explain how endocrine-resistant breast cancer acquires metastatic behavior, opening the possibility of new therapeutic strategies.

Attacking metastatic breast cancer with sound
Drugs can be safely delivered to cancerous lymph nodes via the lymphatic system and then released inside the nodes using sound waves.

Oncolytics Biotech® and PrECOG announce study in metastatic breast cancer
Oncolytics Biotech® Inc., developing pelareorep, an intravenously delivered immuno-oncolytic virus, and PrECOG LLC, today announced the BRACELET-1 (PrE0113) study, to evaluate the ability of pelareorep to make tumors immunologically visible to checkpoint inhibitors.

Study supports germline testing for all metastatic breast cancer patients
Genetic testing for all metastatic breast cancer patients may be an optimal strategy for identifying additional patients with increased risk as well as response to targeted therapies, according to research published in JAMA Oncology.

Adding targeted therapy to treatment extends lives of those with metastatic breast cancer
A UCLA-led study has found that using a drug called ribociclib in combination with a common hormone therapy may help premenopausal women with the most common type of breast cancer live longer than if they only receive the hormone therapy.

New 'smart drug' shows promise for metastatic triple-negative breast cancer
A clinical trial at NewYork-Presbyterian/Columbia and other centers found that patients responded to a new 'smart drug' for women with an aggressive form of breast cancer.

Read More: Metastatic Breast Cancer News and Metastatic Breast Cancer Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.